Sphera Funds Management Ltd. Curis Inc Transaction History

Sphera Funds Management Ltd.

  • $683 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $4.08 Million - $5.21 Million
-588,264 Closed
0 $0
Q2 2021

Aug 17, 2021
SELL
$7.45 - $16.27 $2.22 Million - $4.84 Million
-297,574 Reduced 33.59%
588,264 $4.75 Million
Q1 2021

May 17, 2021
BUY
$8.78 - $12.8 $7.78 Million - $11.3 Million
885,838 New
885,838 $10 Million

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email